N343Remark Code (RARC)Active
N343 Remark Code: TENS Trial Start Date Issue
The N343 remark code indicates that the claim was denied due to a missing, incomplete, or invalid start date for the Transcutaneous Electrical Nerve Stimulator (TENS) trial. This remark supplements an adjustment reason code that specifies the denial, providing further detail about why the claim cannot be processed as submitted.
How It Relates to the Denial
The N343 code typically accompanies adjustment reason codes related to incomplete documentation or missing information. This combination signals that the payer requires specific date information to support the TENS trial claim.
Common Scenarios
1A provider submits a claim for a TENS unit, but the remittance comes back with a denial citing missing information.
→ The N343 remark indicates that the start date for the TENS trial is either not provided or is incorrect. The payer expects this date to be clearly documented.
2A claim for a TENS trial is submitted, but the start date is listed as 'TBD' or not included at all, leading to a denial.
→ The presence of the N343 remark signifies that the payer cannot process the claim until a valid start date for the TENS trial is included.
3A claim for TENS therapy is denied, and the remittance shows N343 alongside another reason code indicating documentation issues.
→ The N343 remark reinforces that the claim denial is specifically due to the absence or invalidity of the trial's start date, necessitating correction before resubmission.
What to Do
- Verify that the TENS trial start date is documented accurately on the claim.
- If the start date is missing, obtain the correct date from the provider and include it in the claim resubmission.
- If the date provided is incorrect, correct it and ensure it meets the payer's requirements before resubmitting.
What to Check
- The claim submission details to confirm the presence of the TENS trial start date.
- The provider's notes or records regarding the TENS trial to ensure the date is accurate.
- Any communication from the payer regarding specific documentation requirements for TENS trials.